tetano
Editor, Senior Moderator
Am J Case Rep
. 2021 Dec 1;22:e933458.
doi: 10.12659/AJCR.933458.
Progressive Pulmonary Fibrosis After Non-Critical COVID-19: A Case Report
Jedediah J Doane[SUP] 1 [/SUP], Kellen S Hirsch[SUP] 1 [/SUP], Justine O Baldwin[SUP] 2 [/SUP], Mark M Wurfel[SUP] 1 [/SUP], Sudhakar N Pipavath[SUP] 3 [/SUP], T Eoin West[SUP] 1 [/SUP]
Affiliations
Abstract
BACKGROUND The COVID-19 global pandemic is ongoing, and despite vaccination efforts, SARS-CoV-2 continues to circulate worldwide. The spectrum of COVID-19 illness is broad, from asymptomatic infection to respiratory failure and acute respiratory distress syndrome (ARDS), and the long-term sequelae of infection are unclear. COVID-19-related pulmonary fibrosis has been previously described in the setting of critical illness and ARDS but has not been well described in cases requiring minimal supplemental oxygen. CASE REPORT We present the case of a 42-year-old man hospitalized with coronavirus disease 2019 (COVID-19) who initially required minimal supplemental oxygen but weeks later developed progressive pulmonary fibrosis requiring high-flow nasal cannula and ICU admission. Using novel computed tomography (CT) imaging processing techniques, we demonstrate progression from initial ground-glass opacities to pulmonary fibrosis and traction bronchiectasis over several months. Additionally, we describe clinical responsiveness to an extended course of corticosteroids. CONCLUSIONS Although pulmonary fibrosis is a known complication of severe COVID-19-related ARDS requiring mechanical ventilation, our report suggests that patients with milder forms of COVID-19 infection may develop post-acute pulmonary fibrosis.
. 2021 Dec 1;22:e933458.
doi: 10.12659/AJCR.933458.
Progressive Pulmonary Fibrosis After Non-Critical COVID-19: A Case Report
Jedediah J Doane[SUP] 1 [/SUP], Kellen S Hirsch[SUP] 1 [/SUP], Justine O Baldwin[SUP] 2 [/SUP], Mark M Wurfel[SUP] 1 [/SUP], Sudhakar N Pipavath[SUP] 3 [/SUP], T Eoin West[SUP] 1 [/SUP]
Affiliations
- PMID: 34848676
- DOI: 10.12659/AJCR.933458
Abstract
BACKGROUND The COVID-19 global pandemic is ongoing, and despite vaccination efforts, SARS-CoV-2 continues to circulate worldwide. The spectrum of COVID-19 illness is broad, from asymptomatic infection to respiratory failure and acute respiratory distress syndrome (ARDS), and the long-term sequelae of infection are unclear. COVID-19-related pulmonary fibrosis has been previously described in the setting of critical illness and ARDS but has not been well described in cases requiring minimal supplemental oxygen. CASE REPORT We present the case of a 42-year-old man hospitalized with coronavirus disease 2019 (COVID-19) who initially required minimal supplemental oxygen but weeks later developed progressive pulmonary fibrosis requiring high-flow nasal cannula and ICU admission. Using novel computed tomography (CT) imaging processing techniques, we demonstrate progression from initial ground-glass opacities to pulmonary fibrosis and traction bronchiectasis over several months. Additionally, we describe clinical responsiveness to an extended course of corticosteroids. CONCLUSIONS Although pulmonary fibrosis is a known complication of severe COVID-19-related ARDS requiring mechanical ventilation, our report suggests that patients with milder forms of COVID-19 infection may develop post-acute pulmonary fibrosis.